{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,26]],"date-time":"2026-10-26T18:28:23Z","timestamp":1793039303681,"version":"4.5.0"},"reference-count":59,"publisher":"Elsevier BV","issue":"1","license":[{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,3,1]],"date-time":"2025-03-01T00:00:00Z","timestamp":1740787200000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2024,11,24]],"date-time":"2024-11-24T00:00:00Z","timestamp":1732406400000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc-nd\/4.0\/"}],"funder":[{"DOI":"10.13039\/100009619","name":"Japan Agency for Medical Research and Development","doi-asserted-by":"publisher","award":["JP22ek0410098"],"award-info":[{"award-number":["JP22ek0410098"]}],"id":[{"id":"10.13039\/100009619","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Chinese Medical Journal Pulmonary and Critical Care Medicine"],"published-print":{"date-parts":[[2025,3]]},"DOI":"10.1016\/j.pccm.2024.11.005","type":"journal-article","created":{"date-parts":[[2025,1,10]],"date-time":"2025-01-10T15:51:31Z","timestamp":1736524291000},"page":"6-11","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":17,"title":["Treatment of allergic bronchopulmonary aspergillosis with biologics"],"prefix":"10.1016","volume":"3","author":[{"ORCID":"https:\/\/orcid.org\/0000-0002-9044-3061","authenticated-orcid":false,"given":"Koichiro","family":"Asano","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Katsuyoshi","family":"Tomomatsu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Naoki","family":"Okada","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Tanaka","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"ORCID":"https:\/\/orcid.org\/0000-0001-5086-9407","authenticated-orcid":false,"given":"Tsuyoshi","family":"Oguma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.pccm.2024.11.005_bib0001","doi-asserted-by":"crossref","first-page":"850","DOI":"10.1111\/cea.12141","article-title":"Allergic bronchopulmonary aspergillosis: review of literature and proposal of new diagnostic and classification criteria","volume":"43","author":"Agarwal","year":"2013","journal-title":"Clin Exp Allergy"},{"key":"10.1016\/j.pccm.2024.11.005_bib0002","doi-asserted-by":"crossref","first-page":"e24","DOI":"10.5415\/apallergy.2018.8.e24","article-title":"Allergic bronchopulmonary mycosis \u2013 pathophysiology, histology, diagnosis, and treatment","volume":"8","author":"Asano","year":"2018","journal-title":"Asia Pac Allergy"},{"key":"10.1016\/j.pccm.2024.11.005_bib0003","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.00061-2024","article-title":"Revised ISHAM-ABPA working group clinical practice guidelines for diagnosing, classifying and treating allergic bronchopulmonary aspergillosis\/mycoses","volume":"63","author":"Agarwal","year":"2024","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2024.11.005_bib0004","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1111\/myc.12423","article-title":"Utility of IgE (total and Aspergillus fumigatus specific) in monitoring for response and exacerbations in allergic bronchopulmonary aspergillosis","volume":"59","author":"Agarwal","year":"2016","journal-title":"Mycoses"},{"key":"10.1016\/j.pccm.2024.11.005_bib0005","doi-asserted-by":"crossref","first-page":"953","DOI":"10.1111\/myc.13640","article-title":"Long-term follow-up of allergic bronchopulmonary aspergillosis treated with glucocorticoids: a study of 182 subjects","volume":"66","author":"Agarwal","year":"2023","journal-title":"Mycoses"},{"key":"10.1016\/j.pccm.2024.11.005_bib0006","doi-asserted-by":"crossref","first-page":"216","DOI":"10.1097\/00000478-198803000-00007","article-title":"Pathologic features of allergic bronchopulmonary aspergillosis","volume":"12","author":"Bosken","year":"1988","journal-title":"Am J Surg Pathol"},{"key":"10.1016\/j.pccm.2024.11.005_bib0007","doi-asserted-by":"crossref","first-page":"571","DOI":"10.1016\/j.jaci.2017.07.048","article-title":"Eosinophils release extracellular DNA traps in response to Aspergillus fumigatus","volume":"141","author":"Muniz","year":"2018","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pccm.2024.11.005_bib0008","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1016\/j.alit.2024.03.002","article-title":"Eosinophilic mucus diseases","volume":"73","author":"Arima","year":"2024","journal-title":"Allergol Int"},{"key":"10.1016\/j.pccm.2024.11.005_bib0009","doi-asserted-by":"crossref","first-page":"1306","DOI":"10.1016\/j.jaci.2023.11.925","article-title":"Aggregated eosinophils and neutrophils characterize the properties of mucus in chronic rhinosinusitis","volume":"153","author":"Miyabe","year":"2024","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pccm.2024.11.005_bib0010","doi-asserted-by":"crossref","first-page":"2183","DOI":"10.1182\/blood-2018-04-842260","article-title":"Charcot-Leyden crystal formation is closely associated with eosinophil extracellular trap cell death","volume":"132","author":"Ueki","year":"2018","journal-title":"Blood"},{"key":"10.1016\/j.pccm.2024.11.005_bib0011","doi-asserted-by":"crossref","first-page":"eaaw4295","DOI":"10.1126\/science.aaw4295","article-title":"Protein crystallization promotes type 2 immunity and is reversible by antibody treatment","volume":"364","author":"Persson","year":"2019","journal-title":"Science"},{"key":"10.1016\/j.pccm.2024.11.005_bib0012","doi-asserted-by":"crossref","first-page":"2933","DOI":"10.1111\/all.15820","article-title":"Allergic bronchopulmonary aspergillosis with atopic, nonatopic, and sans asthma-factor analysis","volume":"78","author":"Okada","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.pccm.2024.11.005_bib0013","doi-asserted-by":"crossref","first-page":"1261","DOI":"10.1016\/j.jaci.2020.08.029","article-title":"New clinical diagnostic criteria for allergic bronchopulmonary aspergillosis\/mycosis and its validation","volume":"147","author":"Asano","year":"2021","journal-title":"J Allergy Clin Immunol"},{"key":"10.1016\/j.pccm.2024.11.005_bib0014","doi-asserted-by":"crossref","first-page":"490","DOI":"10.1183\/13993003.01475-2015","article-title":"A randomised trial of glucocorticoids in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"47","author":"Agarwal","year":"2016","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2024.11.005_bib0015","doi-asserted-by":"crossref","first-page":"656","DOI":"10.1016\/j.chest.2018.01.005","article-title":"A randomized trial of itraconazole vs prednisolone in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"153","author":"Agarwal","year":"2018","journal-title":"Chest"},{"key":"10.1016\/j.pccm.2024.11.005_bib0016","doi-asserted-by":"crossref","DOI":"10.1183\/13993003.01159-2018","article-title":"A randomised trial of voriconazole and prednisolone monotherapy in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"52","author":"Agarwal","year":"2018","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2024.11.005_bib0017","doi-asserted-by":"crossref","first-page":"2519","DOI":"10.2169\/internalmedicine.6807-20","article-title":"Benralizumab as a first-line treatment for ABPA: is it really indicated?","volume":"60","author":"Agarwal","year":"2021","journal-title":"Intern Med"},{"key":"10.1016\/j.pccm.2024.11.005_bib0018","doi-asserted-by":"crossref","first-page":"442","DOI":"10.1378\/chest.130.2.442","article-title":"Allergic bronchopulmonary aspergillosis: lessons from 126 patients attending a chest clinic in north India","volume":"130","author":"Agarwal","year":"2006","journal-title":"Chest"},{"key":"10.1016\/j.pccm.2024.11.005_bib0019","doi-asserted-by":"crossref","first-page":"79","DOI":"10.1016\/j.alit.2017.04.011","article-title":"Allergic bronchopulmonary aspergillosis in Japan: a nationwide survey","volume":"67","author":"Oguma","year":"2018","journal-title":"Allergol Int"},{"key":"10.1016\/j.pccm.2024.11.005_bib0020","doi-asserted-by":"crossref","first-page":"1721","DOI":"10.2169\/internalmedicine.52.9537","article-title":"Allergic bronchopulmonary aspergillosis with repeated isolation of nontuberculous mycobacteria","volume":"52","author":"Ishiguro","year":"2013","journal-title":"Intern Med"},{"key":"10.1016\/j.pccm.2024.11.005_bib0021","doi-asserted-by":"crossref","first-page":"4870","DOI":"10.1128\/AAC.00514-12","article-title":"Correlation between triazole treatment history and susceptibility in clinically isolated Aspergillus fumigatus","volume":"56","author":"Tashiro","year":"2012","journal-title":"Antimicrob Agents Chemother"},{"key":"10.1016\/j.pccm.2024.11.005_bib0022","article-title":"A randomised trial of prednisolone versus prednisolone and itraconazole in acute-stage allergic bronchopulmonary aspergillosis complicating asthma","volume":"59","author":"Agarwal","year":"2021","journal-title":"Eur Respir J"},{"key":"10.1016\/j.pccm.2024.11.005_bib0023","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1016\/j.alit.2022.10.004","article-title":"Treatments of refractory eosinophilic lung diseases with biologics","volume":"72","author":"Asano","year":"2023","journal-title":"Allergol Int"},{"key":"10.1016\/j.pccm.2024.11.005_bib0024","doi-asserted-by":"crossref","first-page":"192","DOI":"10.1016\/j.jaip.2014.12.008","article-title":"Clinical efficacy and immunologic effects of omalizumab in allergic bronchopulmonary aspergillosis","volume":"3","author":"Voskamp","year":"2015","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0025","doi-asserted-by":"crossref","first-page":"896","DOI":"10.1016\/j.jaip.2022.12.012","article-title":"Omalizumab in allergic bronchopulmonary aspergillosis: a systematic review and meta-analysis","volume":"11","author":"Jin","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0026","doi-asserted-by":"crossref","first-page":"2412","DOI":"10.1016\/j.jaip.2020.03.023","article-title":"Mepolizumab for allergic bronchopulmonary aspergillosis: report of 20 cases from the Belgian Severe Asthma Registry and review of the literature","volume":"8","author":"Schleich","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0027","doi-asserted-by":"crossref","first-page":"2315","DOI":"10.1016\/j.jaip.2021.02.048","article-title":"Real-world effectiveness of anti-IL-5\/5R therapy in severe atopic eosinophilic asthma with fungal sensitization","volume":"9","author":"Dhariwal","year":"2021","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0028","doi-asserted-by":"crossref","first-page":"112","DOI":"10.1016\/j.ejim.2021.12.026","article-title":"One-year mepolizumab for allergic bronchopulmonary aspergillosis: Focus on steroid sparing effect and markers of response","volume":"99","author":"Caminati","year":"2022","journal-title":"Eur J Intern Med"},{"key":"10.1016\/j.pccm.2024.11.005_bib0029","doi-asserted-by":"crossref","first-page":"5468","DOI":"10.1038\/s41598-023-32246-8","article-title":"Real-world efficacy of anti-IL-5 treatment in patients with allergic bronchopulmonary aspergillosis","volume":"13","author":"Tomomatsu","year":"2023","journal-title":"Sci Rep"},{"key":"10.1016\/j.pccm.2024.11.005_bib0030","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1016\/j.jaip.2014.08.007","article-title":"Allergic bronchopulmonary aspergillosis","volume":"2","author":"Greenberger","year":"2014","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0031","doi-asserted-by":"crossref","first-page":"906","DOI":"10.1016\/j.jaip.2023.01.013","article-title":"Defining the outcome markers and therapeutic role for omalizumab in treatment of allergic bronchopulmonary aspergillosis","volume":"11","author":"Greenberger","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0032","doi-asserted-by":"crossref","first-page":"539","DOI":"10.1136\/thx.2010.153312","article-title":"Effects of omalizumab in Aspergillus-associated airway disease","volume":"66","author":"P\u00e9rez-de-Llano","year":"2011","journal-title":"Thorax"},{"key":"10.1016\/j.pccm.2024.11.005_bib0033","doi-asserted-by":"crossref","first-page":"1254","DOI":"10.1111\/j.1398-9995.2011.02599.x","article-title":"Allergic bronchopulmonary aspergillosis and omalizumab","volume":"66","author":"Tillie-Leblond","year":"2011","journal-title":"Allergy"},{"key":"10.1016\/j.pccm.2024.11.005_bib0034","doi-asserted-by":"crossref","first-page":"493","DOI":"10.2500\/aap.2015.36.3909","article-title":"Omalizumab in the treatment of allergic bronchopulmonary aspergillosis: one center's experience with 14 cases","volume":"36","author":"Ayd\u0131n","year":"2015","journal-title":"Allergy Asthma Proc"},{"key":"10.1016\/j.pccm.2024.11.005_bib0035","doi-asserted-by":"crossref","first-page":"499","DOI":"10.1159\/000507216","article-title":"Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis complicated by chronic bacterial infection in the airways","volume":"181","author":"Tomomatsu","year":"2020","journal-title":"Int Arch Allergy Immunol"},{"key":"10.1016\/j.pccm.2024.11.005_bib0036","doi-asserted-by":"crossref","first-page":"3428","DOI":"10.1016\/j.jaip.2020.05.055","article-title":"Omalizumab is an effective intervention in severe asthma with fungal sensitization","volume":"8","author":"Wark","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0037","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1186\/s12890-023-02696-x","article-title":"Effectiveness and safety of omalizumab in patients with allergic bronchopulmonary aspergillosis with or without allergic rhinitis: a retrospective chart review","volume":"23","author":"Cai","year":"2023","journal-title":"BMC Pulm Med"},{"key":"10.1016\/j.pccm.2024.11.005_bib0038","doi-asserted-by":"crossref","first-page":"6","DOI":"10.1007\/s10238-023-01267-y","article-title":"Efficacy of omalizumab in adult patients with allergic bronchopulmonary aspergillosis: a multicentre study in China","volume":"24","author":"Chen","year":"2024","journal-title":"Clin Exp Med"},{"key":"10.1016\/j.pccm.2024.11.005_bib0039","doi-asserted-by":"crossref","first-page":"26","DOI":"10.23822\/EurAnnACI.1764-1489.261","article-title":"Can dose reduction be made in patients with allergic bronchopulmonary aspergillosis receiving high-dose omalizumab treatment?","volume":"56","author":"Korkmaz","year":"2024","journal-title":"Eur Ann Allergy Clin Immunol"},{"key":"10.1016\/j.pccm.2024.11.005_bib0040","doi-asserted-by":"crossref","first-page":"503","DOI":"10.1002\/ppul.22937","article-title":"Omalizumab therapy for allergic bronchopulmonary aspergillosis in children with cystic fibrosis: a synthesis of published evidence","volume":"49","author":"Tanou","year":"2014","journal-title":"Pediatr Pulmonol"},{"key":"10.1016\/j.pccm.2024.11.005_bib0041","doi-asserted-by":"crossref","DOI":"10.1016\/j.waojou.2023.100787","article-title":"Omalizumab for the treatment of patients with severe allergic asthma with immunoglobulin E levels above >1500 IU\/mL","volume":"16","author":"Menzella","year":"2023","journal-title":"World Allergy Organ J"},{"key":"10.1016\/j.pccm.2024.11.005_bib0042","doi-asserted-by":"crossref","first-page":"636","DOI":"10.1016\/j.alit.2020.03.003","article-title":"Rapid clearance of mepolizumab-resistant bronchial mucus plugs in allergic bronchopulmonary aspergillosis with benralizumab treatment","volume":"69","author":"Tomomatsu","year":"2020","journal-title":"Allergol Int"},{"key":"10.1016\/j.pccm.2024.11.005_bib0043","doi-asserted-by":"crossref","first-page":"3154","DOI":"10.1111\/all.15909","article-title":"Blood CD62Llow inflammatory eosinophils are related to the severity of asthma and reduced by mepolizumab","volume":"78","author":"Vultaggio","year":"2023","journal-title":"Allergy"},{"key":"10.1016\/j.pccm.2024.11.005_bib0044","doi-asserted-by":"crossref","first-page":"1137","DOI":"10.1016\/j.jaip.2017.01.013","article-title":"Combination omalizumab and mepolizumab therapy for refractory allergic bronchopulmonary aspergillosis","volume":"5","author":"Altman","year":"2017","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0045","doi-asserted-by":"crossref","first-page":"742","DOI":"10.1016\/j.jaip.2019.11.031","article-title":"Dupilumab treatment for allergic bronchopulmonary aspergillosis: a case series","volume":"8","author":"Ramonell","year":"2020","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0046","doi-asserted-by":"crossref","first-page":"omaa029","DOI":"10.1093\/omcr\/omaa029","article-title":"Dupilumab: a new contestant to corticosteroid in allergic bronchopulmonary aspergillosis","volume":"2021","author":"Ali","year":"2021","journal-title":"Oxf Med Case Reports"},{"key":"10.1016\/j.pccm.2024.11.005_bib0047","doi-asserted-by":"crossref","first-page":"2839","DOI":"10.2169\/internalmedicine.6679-20","article-title":"Successful treatment of mepolizumab- and prednisolone-resistant allergic bronchopulmonary aspergillosis with dupilumab","volume":"60","author":"Mikura","year":"2021","journal-title":"Intern Med"},{"key":"10.1016\/j.pccm.2024.11.005_bib0048","doi-asserted-by":"crossref","first-page":"6922","DOI":"10.12998\/wjcc.v9.i23.6922","article-title":"Complete withdrawal of glucocorticoids after dupilumab therapy in allergic bronchopulmonary aspergillosis: a case report","volume":"9","author":"Nishimura","year":"2021","journal-title":"World J Clin Cases"},{"key":"10.1016\/j.pccm.2024.11.005_bib0049","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.alit.2020.08.006","article-title":"Efficacy of dupilumab and biomarkers for systemic corticosteroid naive allergic bronchopulmonary mycosis","volume":"70","author":"Tashiro","year":"2021","journal-title":"Allergol Int"},{"key":"10.1016\/j.pccm.2024.11.005_bib0050","doi-asserted-by":"crossref","first-page":"e12081","DOI":"10.1002\/clt2.12081","article-title":"Reduced exacerbation frequency and prednisone dose in patients with ABPA and asthma treated with dupilumab","volume":"11","author":"van der Veer","year":"2021","journal-title":"Clin Transl Allergy"},{"key":"10.1016\/j.pccm.2024.11.005_bib0051","article-title":"Successful management of recurrent allergic bronchopulmonary aspergillosis after changing from mepolizumab to dupilumab: a case report","volume":"39","author":"Kai","year":"2022","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.pccm.2024.11.005_bib0052","first-page":"e42464","article-title":"A case of allergic bronchopulmonary aspergillosis with failure of benralizumab and response to dupilumab","volume":"15","author":"Kotetsu","year":"2023","journal-title":"Cureus"},{"key":"10.1016\/j.pccm.2024.11.005_bib0053","doi-asserted-by":"crossref","first-page":"1556","DOI":"10.1016\/j.jaip.2022.12.049","article-title":"Allergic bronchopulmonary aspergillosis in identical twins: effectiveness of dupilumab","volume":"11","author":"Lamothe","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0054","doi-asserted-by":"crossref","first-page":"e01354","DOI":"10.1002\/rcr2.1354","article-title":"Efficacy of dupilumab as an alternative to corticosteroids in the treatment of exacerbations of allergic bronchopulmonary aspergillosis","volume":"12","author":"Hamakawa","year":"2024","journal-title":"Respirol Case Rep"},{"key":"10.1016\/j.pccm.2024.11.005_bib0055","article-title":"Successful treatment with dupilumab in mepolizumab-resistant allergic bronchopulmonary aspergillosis","volume":"47","author":"Kawasaki","year":"2023","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.pccm.2024.11.005_bib0056","first-page":"e55884","article-title":"Successful treatment of mucus plug due to allergic bronchopulmonary aspergillosis using dupilumab","volume":"16","author":"Sumi","year":"2024","journal-title":"Cureus"},{"key":"10.1016\/j.pccm.2024.11.005_bib0057","article-title":"Mepolizumab and dupilumab as a replacement to systemic glucocorticoids for the treatment of chronic eosinophilic pneumonia and allergic bronchopulmonary aspergillosis \u2013 case series, Almoosa specialist hospital","volume":"34","author":"Eldaabossi","year":"2021","journal-title":"Respir Med Case Rep"},{"key":"10.1016\/j.pccm.2024.11.005_bib0058","doi-asserted-by":"crossref","first-page":"2589","DOI":"10.1016\/j.jaip.2023.05.026","article-title":"Allergic bronchopulmonary aspergillosis successfully treated with tezepelumab","volume":"11","author":"Matsuno","year":"2023","journal-title":"J Allergy Clin Immunol Pract"},{"key":"10.1016\/j.pccm.2024.11.005_bib0059","doi-asserted-by":"crossref","first-page":"e01147","DOI":"10.1002\/rcr2.1147","article-title":"Tezepelumab treatment for allergic bronchopulmonary aspergillosis","volume":"11","author":"Ogata","year":"2023","journal-title":"Respirol Case Rep"}],"container-title":["Chinese Medical Journal Pulmonary and Critical Care Medicine"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772558824000896?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S2772558824000896?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2025,4,1]],"date-time":"2025-04-01T07:13:54Z","timestamp":1743491634000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S2772558824000896"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,3]]},"references-count":59,"journal-issue":{"issue":"1","published-print":{"date-parts":[[2025,3]]}},"alternative-id":["S2772558824000896"],"URL":"https:\/\/doi.org\/10.1016\/j.pccm.2024.11.005","relation":{},"ISSN":["2772-5588"],"issn-type":[{"value":"2772-5588","type":"print"}],"subject":[],"published":{"date-parts":[[2025,3]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Treatment of allergic bronchopulmonary aspergillosis with biologics","name":"articletitle","label":"Article Title"},{"value":"Chinese Medical Journal Pulmonary and Critical Care Medicine","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.pccm.2024.11.005","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2024 The Author(s). Published by Elsevier B.V. on behalf of Chinese Medical Association.","name":"copyright","label":"Copyright"}]}}